Ratings by Citi (Liav Abraham)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/9/2022 | Endo International plc | ENDP | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2021 | Endo International plc | ENDP | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2021 | Teva Pharma | TEVA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2021 | Endo International plc | ENDP | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2021 | Endo International plc | ENDP | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2020 | Teva Pharma | TEVA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/15/2020 | Elanco Animal Health | ELAN | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2020 | Endo International plc | ENDP | New Coverage | Buy (N/A) |
3.39 (0.29) |
-91.45% | Details | |
| 7/31/2019 | Mylan | MYL | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2019 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 6/17/2019 | Endo International plc | ENDP | Downgrade | Neutral (Buy) |
4.47 (0.29) |
-93.51% | Details | |
| 5/1/2019 | Horizon Pharma | HZNP | Upgrade | Buy (Neutral) |
26.15 (116.30) |
344.74% | Details | |
| 5/1/2019 | Alkermes | ALKS | Downgrade | Neutral (Buy) |
30.28 (24.65) |
-18.59% | Details | |
| 4/18/2019 | Mylan | MYL | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2019 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2019 | Insmed | INSM | Maintain | Neutral (N/A) |
|
Details | ||
| 4/3/2019 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2019 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2018 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | Elanco Animal Health | ELAN | New Coverage | Buy (N/A) |
32.39 (13.31) |
-58.91% | Details | |
| 9/5/2018 | Horizon Pharma | HZNP | Maintain | Neutral (N/A) |
|
Details | ||
| 8/13/2018 | Endo International plc | ENDP | Maintain | Buy (N/A) |
|
Details |
